Free Trial

Medicenna Therapeutics (MDNA) Institutional Ownership

→ Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad)
Free MDNA Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Stock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipSocial Media

Institutional Ownership Changes (13F Filings) for Medicenna Therapeutics (NASDAQ:MDNA)

Current
Institutional Ownership
Percentage
12.38%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$97.10K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$24.09K
Get MDNA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Medicenna Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

MDNA Institutional Buying and Selling by Quarter

Medicenna Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/6/2023Sigma Planning Corp634,550$187K0.0%+107.8%0.911%
8/10/2023Letko Brosseau & Associates Inc.120,000$58K0.0%-29.4%0.172%
2/16/2023AIGH Capital Management LLC4,346,983$1.99M0.7%+12.9%6.242%
2/10/2023Letko Brosseau & Associates Inc.170,000$78K0.0%+70.0%0.244%
2/9/2023Tocqueville Asset Management L.P.79,000$37K0.0%-32.8%0.113%
1/24/2023Sigma Planning Corp302,550$139K0.0%+15.0%0.434%
11/16/2022Maven Securities LTD150,000$124K0.0%N/A0.215%
11/15/2022Empery Asset Management LP589,316$489K2.9%N/A0.846%
11/14/2022Annandale Capital LLC40,000$33K0.0%N/A0.057%
11/14/2022Worth Venture Partners LLC963,801$799K0.5%+68.6%1.384%
11/14/2022Maven Securities LTD150,000$124K0.0%N/A0.215%
11/4/2022Granite Point Capital Management L.P.325,000$270K0.1%N/A0.467%
11/3/2022Rathbones Group Plc105,663$87K0.0%+164.2%0.152%
8/11/2022Toronto Dominion Bank29,103$33K0.0%+1,452.2%0.052%
8/11/2022Sigma Planning Corp252,050$292K0.0%+25.8%0.448%
5/12/2022AIGH Capital Management LLC2,272,700$2.91M0.7%+2.6%4.084%
4/27/2022McKinley Carter Wealth Services Inc.79,259$101K0.0%+529.3%0.142%
4/20/2022Sigma Planning Corp200,300$256K0.0%+43.0%0.360%
2/10/2022AIGH Capital Management LLC2,214,300$3.61M1.1%+142.0%3.985%
2/3/2022ACT Capital Management LLC152,500$249K0.2%-56.4%0.274%
2/2/2022Sigma Planning Corp140,050$228K0.0%+359.2%0.252%
11/15/2021Tocqueville Asset Management L.P.93,000$258K0.0%-4.8%0.173%
11/12/2021Vident Investment Advisory LLC62,880$172K0.0%N/A0.117%
11/5/2021Advisor Group Holdings Inc.19,676$54K0.0%+635.3%0.037%
11/5/2021K.J. Harrison & Partners Inc10,000$27K0.0%N/A0.019%
11/4/2021Deutsche Bank AG22,900$64K0.0%+179.3%0.043%
11/3/2021Letko Brosseau & Associates Inc.100,000$277K0.0%N/A0.186%
10/28/2021Sigma Planning Corp30,500$84K0.0%N/A0.057%
10/7/2021Newman Dignan & Sheerar Inc.12,915$36K0.0%N/A0.024%
8/17/2021Worth Venture Partners LLC215,030$647K0.2%+8.7%0.400%
8/16/2021Maven Securities LTD79,118$234K0.0%-57.9%0.147%
8/16/2021Tocqueville Asset Management L.P.97,700$294K0.0%+5.5%0.182%
8/13/2021Renaissance Technologies LLC32,446$98K0.0%-77.0%0.060%
8/12/2021AIGH Capital Management LLC915,000$2.77M0.5%+8.9%1.703%
8/12/2021JPMorgan Chase & Co.25,500$77K0.0%+171.3%0.047%
8/12/2021Bank of Montreal Can45,250$144K0.0%+403.5%0.084%
8/12/2021McKinley Carter Wealth Services Inc.32,237$97K0.0%+28.5%0.060%
7/28/2021DAVENPORT & Co LLC25,150$76K0.0%N/A0.047%
5/19/2021Worth Venture Partners LLC197,900$807K0.4%N/A0.370%
5/18/2021Millennium Management LLC122,488$500K0.0%N/A0.229%
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>
5/17/2021Royal Bank of Canada11,428$47K0.0%-51.2%0.021%
5/17/2021Janus Henderson Group PLC529,325$2.15M0.0%N/A0.989%
5/17/2021Goldman Sachs Group Inc.36,902$151K0.0%N/A0.069%
5/14/2021Board of Trustees of The Leland Stanford Junior University962,932$3.91M0.3%N/A1.798%
5/13/2021Renaissance Technologies LLC141,200$574K0.0%+8.2%0.264%
5/12/2021Geode Capital Management LLC19,762$80K0.0%N/A0.037%
5/12/2021JPMorgan Chase & Co.9,400$38K0.0%+131.1%0.018%
2/18/2021Verition Fund Management LLC539,651$2.53M0.0%N/A1.068%
2/16/2021Silverarc Capital Management LLC107,536$503K0.3%N/A0.213%
2/10/2021Renaissance Technologies LLC130,500$608K0.0%-43.2%0.258%
2/5/2021BlackRock Inc.5,775$27K0.0%N/A0.011%
1/29/2021Creative Planning39,000$183K0.0%+35.5%0.077%
11/17/2020VR Adviser LLC92,453$383K0.1%N/A0.189%
11/13/2020AWM Investment Company Inc.1,000,000$4.11M0.7%N/A2.044%
11/12/2020JPMorgan Chase & Co.22,200$104K0.0%N/A0.045%
(Data available from 1/1/2016 forward)

MDNA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of MDNA shares?

During the previous two years, 12 institutional investors and hedge funds held shares of Medicenna Therapeutics. The most heavily invested institutionals were AIGH Capital Management LLC ($1.99M), Worth Venture Partners LLC ($799K), Empery Asset Management LP ($489K), Granite Point Capital Management L.P. ($270K), Sigma Planning Corp ($187K), Maven Securities LTD ($124K), and McKinley Carter Wealth Services Inc. ($101K).Learn more on MDNA's institutional investors.

What percentage of Medicenna Therapeutics stock is owned by institutional investors?

12.38% of Medicenna Therapeutics stock is owned by institutional investors. Learn more on MDNA's institutional investor holdings.

Which institutional investors have been buying Medicenna Therapeutics stock?

Of the 11 institutional investors that purchased Medicenna Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Empery Asset Management LP ($589.32K), AIGH Capital Management LLC ($555.23K), Sigma Planning Corp ($420.50K), Worth Venture Partners LLC ($392.31K), Granite Point Capital Management L.P. ($325K), Maven Securities LTD ($300K), and Letko Brosseau & Associates Inc. ($70K).

How much institutional buying is happening at Medicenna Therapeutics?

Institutional investors have bought a total of 2,851,913 shares in the last 24 months. This purchase volume represents approximately $2.05M in transactions.

Which Medicenna Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Medicenna Therapeutics stock in the last 24 months: Letko Brosseau & Associates Inc. ($50K), and Tocqueville Asset Management L.P. ($38.50K).

How much institutional selling is happening at Medicenna Therapeutics?

Institutional investors have sold a total of 88,500 shares in the last 24 months. This volume of shares sold represents approximately $41.72K in transactions.


Related Companies:
This page (NASDAQ:MDNA) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
These AI trades triggered this morning (545% return)
Prosper Trading Academy
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
He Is Giving Away Bitcoin
Crypto Swap Profits
Jim Cramer’s “The Biggest Drug Ever”
Behind the Markets
Your Money is Not Safe
American Alternative
The AI stock to buy right now
StockEarnings
The only accurate crypto trading system I know …
Weiss Ratings